Shillong, Oct 6 (UNI) The Employees’ State Insurance Corporation (ESIC) launched two major initiatives- the Scheme for Promoting Registration of Employers and Employees (SPREE 2025) and the Amnesty ...

ESIC launched a one-time Amnesty Scheme (Oct 2025-Sept 2026) to settle pending court cases on ESI contribution, coverage, and damages, promoting ...

In a major step aimed at reducing litigation and improving ease of doing business, the Employees' State Insurance Corporation (ESIC) has launched the Amnesty Scheme 2025, offering a one-time ...

Invites comments on draft policy, broad goals include universal and portable social security, occupational safety and health, skill and employment linkages, ease of compliance and formalisation.

ITAT Lucknow held that claim has been allowed by AO in scrutiny proceedings u/s 143(3) of the Act, it was natural that the demand raised on the same issue under section 143(1)(a) of the Act is ...

EDWARDSVILLE — Bohemian Queen, a Queen tribute band, will perform at The Wildey Theatre, located at 252 N. Main St. in Edwardsville, at 7:30 p.m. on Thursday, Oct. 9. Veteran touring musicians Paulie ...

The Medical Counselling Committee (MCC) will close NEET UG 2025 round 3 counselling registration today, October 5, at mcc.nic.in. While registration ends, the choice filling deadline has been extended ...

The Shram Shakti Niti 2025 envisions a resilient, digitally empowered, and continuously skilled workforce capable of adapting to technological, environmental, and demographic shifts.

The National Hurricane Center on Monday continued to give high chances that a system in the Atlantic will develop into the season’s next tropical depression or storm and threaten the Caribbean. As of ...

The prestigious award, presented during the World Social Security Forum held in Kuala Lumpur, Malaysia, marks a milestone in India’s global leadership in social security governance.

A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...